🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

135,26 USD

Máx. histórico

158,62

80 días

Caída desde máximo

-14,73%

Rango 52 semanas

76,70 – 160,81

Variación hoy

-5,66%

Cierre anterior

143,37

Rango de hoy

134,39 – 143,30

Volumen hoy

582.605

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,33%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
131,32 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 4 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/03/2020 7,83 7,95 7,66 7,92 +1,54% 3,70% 104.700
28/02/2020 7,59 7,92 7,50 7,80 -0,26% 5,53% 195.200
27/02/2020 8,20 8,20 7,68 7,82 -6,01% 6,34% 313.400
26/02/2020 8,65 8,70 8,21 8,32 -2,80% 5,66% 221.100
25/02/2020 8,89 9,00 8,39 8,56 -3,71% 6,86% 165.700
24/02/2020 8,82 8,94 8,64 8,89 -1,88% 3,40% 78.400
21/02/2020 9,26 9,26 8,92 9,06 -1,74% 3,67% 105.200
20/02/2020 8,80 9,30 8,69 9,22 +4,54% 6,93% 144.200
19/02/2020 8,61 8,84 8,51 8,82 +2,68% 3,83% 91.800
18/02/2020 8,36 8,66 8,19 8,59 +2,87% 5,62% 120.900
14/02/2020 8,56 8,67 8,28 8,35 -2,79% 4,61% 159.900
13/02/2020 8,33 8,63 8,24 8,59 +3,00% 4,63% 88.600
12/02/2020 8,43 8,47 8,23 8,34 -0,48% 2,85% 120.000
11/02/2020 8,45 8,60 8,27 8,38 +0,12% 3,87% 139.300
10/02/2020 8,26 8,44 8,01 8,37 +1,82% 5,17% 78.400
07/02/2020 8,25 8,47 8,07 8,22 -1,91% 4,88% 216.400
06/02/2020 8,28 8,58 8,09 8,38 +1,70% 5,92% 175.000
05/02/2020 8,03 8,38 8,01 8,24 +3,26% 4,61% 128.300
04/02/2020 7,95 8,05 7,81 7,98 +1,40% 3,02% 132.900
03/02/2020 7,58 7,99 7,50 7,87 +4,24% 6,46% 198.700
31/01/2020 7,33 7,57 7,22 7,55 +2,86% 4,77% 157.000
30/01/2020 7,55 7,57 7,26 7,34 -3,17% 4,11% 179.400
29/01/2020 7,41 7,62 7,29 7,58 +2,43% 4,45% 116.400
28/01/2020 7,29 7,42 7,15 7,40 +1,93% 3,70% 78.800
27/01/2020 7,43 7,43 7,18 7,26 -3,46% 3,36% 203.700
24/01/2020 7,46 7,70 7,38 7,52 +1,21% 4,29% 255.600
23/01/2020 7,61 7,61 7,27 7,43 -2,62% 4,53% 194.900
22/01/2020 7,43 7,66 7,30 7,63 +2,76% 4,86% 138.500
21/01/2020 7,35 7,47 7,24 7,43 +1,71% 3,20% 170.600
17/01/2020 7,22 7,46 7,11 7,30 +1,96% 4,85% 223.600